A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction

Table 3

Association between DSG2 expression and the clinicopathological parameters of cervical cancer patients.

Clinicopathological parameters		Low expression	High expression	value
Age	<50 years	82	98	0.061
	>50 years	69	53
HPV status	Negative	9	0	0.016
	Positive	90	79
Histology	Adenocarcinoma	18	13	0.373
	Adenosquamous	3	0
	Squamous	78	66
Stage	I-II	78	63	0.803
	III-IV	18	16
Lymph node metastasis	Positive	15	18	0.054
	Negative	57	31

.